Clinical Trial Update: A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating radotinib for chronic myeloid leukemia in chronic phase patients who failed or were intolerant to prior…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Radotinib (radotinib)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase | Phase 3 | Status: RECRUITING